BG107803A - Репинотанов кит - Google Patents

Репинотанов кит Download PDF

Info

Publication number
BG107803A
BG107803A BG107803A BG10780303A BG107803A BG 107803 A BG107803 A BG 107803A BG 107803 A BG107803 A BG 107803A BG 10780303 A BG10780303 A BG 10780303A BG 107803 A BG107803 A BG 107803A
Authority
BG
Bulgaria
Prior art keywords
acid
repinotan
solution
kit according
concentration
Prior art date
Application number
BG107803A
Other languages
Bulgarian (bg)
English (en)
Inventor
Werner Kroll
Ferdinand Rombout
Horst Weber
Maria-Luisa Rodriguez
Bernd Sennhenn
Rudolf Schohe-Loop
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG107803A publication Critical patent/BG107803A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BG107803A 2000-11-22 2003-05-12 Репинотанов кит BG107803A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10058119A DE10058119A1 (de) 2000-11-22 2000-11-22 Pepinotan-Kit
PCT/EP2001/012968 WO2002041881A2 (de) 2000-11-22 2001-11-09 Repinotan-kit

Publications (1)

Publication Number Publication Date
BG107803A true BG107803A (bg) 2004-01-30

Family

ID=7664358

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107803A BG107803A (bg) 2000-11-22 2003-05-12 Репинотанов кит

Country Status (37)

Country Link
US (2) US6605255B2 (xx)
EP (1) EP1339403B1 (xx)
JP (2) JP2004517824A (xx)
KR (1) KR20030096237A (xx)
CN (2) CN1715279A (xx)
AR (1) AR031761A1 (xx)
AT (1) ATE284212T1 (xx)
AU (1) AU2002227912A1 (xx)
BG (1) BG107803A (xx)
BR (1) BR0115518A (xx)
CA (1) CA2429310A1 (xx)
CZ (1) CZ20031401A3 (xx)
DE (2) DE10058119A1 (xx)
DO (1) DOP2001000293A (xx)
EC (1) ECSP034617A (xx)
EE (1) EE200300242A (xx)
ES (1) ES2234922T3 (xx)
GT (1) GT200100236A (xx)
HN (1) HN2001000262A (xx)
HR (1) HRP20030490A2 (xx)
HU (1) HUP0303294A2 (xx)
IL (1) IL155975A0 (xx)
MA (1) MA26059A1 (xx)
MX (1) MXPA03004499A (xx)
MY (1) MY118345A (xx)
NO (1) NO20032212D0 (xx)
NZ (1) NZ525964A (xx)
PE (1) PE20020533A1 (xx)
PL (1) PL361628A1 (xx)
PT (1) PT1339403E (xx)
RU (1) RU2003118583A (xx)
SI (1) SI1339403T1 (xx)
SK (1) SK5922003A3 (xx)
SV (1) SV2003000744A (xx)
UY (1) UY27027A1 (xx)
WO (1) WO2002041881A2 (xx)
ZA (1) ZA200303888B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004010050A1 (de) * 2004-03-02 2005-09-22 Bayer Healthcare Ag Spezifische monoklonale und polyklonale Antikörper für Repinotan und dessen ringoffene Form
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
WO2009019205A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19543476A1 (de) * 1995-11-22 1997-05-28 Troponwerke Gmbh & Co Kg Verwendung von substituierten Aminomethyl-chromanen zur Behandlung von Schädel-Hirn-Trauma
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
DE19754573A1 (de) * 1997-12-09 1999-06-10 Bayer Ag Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma
CA2324096A1 (en) * 1998-03-10 1999-09-16 Strategic Diagnostics, Inc. Integrated assay device and methods of production and use
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung

Also Published As

Publication number Publication date
NZ525964A (en) 2006-02-24
JP2005232189A (ja) 2005-09-02
PE20020533A1 (es) 2002-07-13
CN1518446A (zh) 2004-08-04
CN1715279A (zh) 2006-01-04
HUP0303294A2 (en) 2007-09-28
DE10058119A1 (de) 2002-05-23
MA26059A1 (fr) 2004-04-01
US6605255B2 (en) 2003-08-12
PL361628A1 (en) 2004-10-04
US20030060493A1 (en) 2003-03-27
CZ20031401A3 (cs) 2003-10-15
EE200300242A (et) 2003-10-15
MXPA03004499A (es) 2004-05-14
JP2004517824A (ja) 2004-06-17
ATE284212T1 (de) 2004-12-15
IL155975A0 (en) 2003-12-23
ZA200303888B (en) 2004-05-20
EP1339403B1 (de) 2004-12-08
DOP2001000293A (es) 2002-03-15
RU2003118583A (ru) 2004-12-20
EP1339403A2 (de) 2003-09-03
AU2002227912A1 (en) 2002-06-03
GT200100236A (es) 2002-06-25
WO2002041881A2 (de) 2002-05-30
AR031761A1 (es) 2003-10-01
BR0115518A (pt) 2003-09-16
SV2003000744A (es) 2003-01-13
ECSP034617A (es) 2003-06-25
SK5922003A3 (en) 2003-11-04
KR20030096237A (ko) 2003-12-24
NO20032212L (no) 2003-05-15
WO2002041881A3 (de) 2002-10-10
MY118345A (en) 2004-10-30
DE50104790D1 (de) 2005-01-13
SI1339403T1 (en) 2005-04-30
NO20032212D0 (no) 2003-05-15
CA2429310A1 (en) 2002-05-30
PT1339403E (pt) 2005-03-31
HRP20030490A2 (hr) 2005-06-30
UY27027A1 (es) 2002-07-31
ES2234922T3 (es) 2005-07-01
HN2001000262A (es) 2002-01-30
US20030203953A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
BG107803A (bg) Репинотанов кит
CA2733497C (en) Anti-hepcidin-25 selective antibodies and uses thereof
EP1984744A1 (en) Methods and kits to diagnose growth hormone deficiency
Merimee et al. Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus
Marinò et al. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy
US6800608B2 (en) Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator
JPH06104064B2 (ja) 安定化酵素結合体組成物
Nagataki et al. Binding of fluorescein monoglucuronide to human serum albumin.
JP2004325192A (ja) 金コロイド凝集法によるハプテンの測定方法および測定キット
US6503724B1 (en) Fibrinopeptides in saliva as indicator of blood coagulation status
US20230173021A1 (en) IL-18 Binding Protein (IL-18BP) In Respiratory Diseases
JP4442340B2 (ja) 抗体、それを含有する吸着剤、および免疫測定試薬
JP3479453B2 (ja) 尿中テガフールの測定法
WO2023166206A1 (en) Il-18 binding protein (il-18bp) in the treatment of vexas
JP3973424B2 (ja) テルビナフィンに対する特異的モノクローナル抗体
SOMA et al. Maternal-to-fetal transfer of ritodrine in twin pregnancy
McPhaul et al. Nephrotoxic canine glomerulonephritis
Chaibva Development and Assessment of an Oxytocin Parenteral Dosage Form Prepared Using Pluronic® F127
Rojas et al. Assessment of serum luteinizing hormone during ovarian stimulation with gonadortrophins
Binnie Development of reference ELISA assays for urinary oestrone-3¯-glucuronide and pregnanediol-3¯-glucuronide using timed urine specimens: a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Biochemistry at Massey University
Mägerlein et al. P142 immunological detection of human parathyroid hormone 1–37 (hPTH 1–37), the physiologically circulating fragment of hPTH
JP2003004735A (ja) モルヒネの免疫測定法および測定キット
JPH0394694A (ja) ヒト胎児性膵蛋白質に対するモノクローナル抗体およびその使用方法
Donovan The regulation of human 11b-hydroxysteroid dehydrogenase
BR112016004772B1 (pt) Método para determinação da quantidade de il-18 livre em uma amostra ou in situ, uso de um inibidor de il-18, e, kit de diagnóstico para detectar il-18 livre